#QSQT | Pharma companies might see some slowdown in profit growth in Q3. Analysts expect sales to grow around 10-12% and EBITDA to sustain around 13-15%. @vinnii_motiwala lines up all the key expectations from the pharma sector in our special Quarter Se Quarter Tak segment #Cipla #ApolloHospitals #DRL
#qsqt
#QSQT #Cipla